{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T05:02:06Z","timestamp":1777438926122,"version":"3.51.4"},"reference-count":50,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2020,5,19]]},"DOI":"10.3233\/jad-191335","type":"journal-article","created":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T15:12:49Z","timestamp":1585667569000},"page":"417-427","source":"Crossref","is-referenced-by-count":7,"title":["Interaction between Apolipoprotein E and Butyrylcholinesterase Genes on Risk of Alzheimer\u2019s Disease in a Prospective Cohort Study"],"prefix":"10.1177","volume":"75","author":[{"given":"Yi-Fang","family":"Chuang","sequence":"first","affiliation":[{"name":"Institute of Public Health, National Yang-Ming University, Taipei, Taiwan"},{"name":"Clinical and Translational Neuroscience Section, Laboratory of Behavioral Neuroscience, National Institute on Aging, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay","family":"Varma","sequence":"additional","affiliation":[{"name":"Clinical and Translational Neuroscience Section, Laboratory of Behavioral Neuroscience, National Institute on Aging, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"An","sequence":"additional","affiliation":[{"name":"Laboratory of Behavioral Neuroscience, National Institute on Aging, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiko","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Translational Gerontology Branch, National Institute on Aging, National Institute on Aging, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Davatzikos","sequence":"additional","affiliation":[{"name":"Center for Biomedical Image Computing and Analytics, University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan M.","family":"Resnick","sequence":"additional","affiliation":[{"name":"Laboratory of Behavioral Neuroscience, National Institute on Aging, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhav","family":"Thambisetty","sequence":"additional","affiliation":[{"name":"Clinical and Translational Neuroscience Section, Laboratory of Behavioral Neuroscience, National Institute on Aging, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-191335_ref1","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1093\/hmg\/ddp406","article-title":"Genome-wide association studies in Alzheimer\u2019s disease","volume":"18","author":"Bertram","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JAD-191335_ref2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.neuron.2010.10.013","article-title":"The genetics of Alzheimer disease: Back to the future","volume":"68","author":"Bertram","year":"2010","journal-title":"Neuron"},{"key":"10.3233\/JAD-191335_ref3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1001\/jama.1995.03520290026015","article-title":"Apolipoprotein E E4 allele and risk of dementia.374-375; author reply","volume":"273","author":"Roses","year":"1995","journal-title":"JAMA"},{"key":"10.3233\/JAD-191335_ref4","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA"},{"key":"10.3233\/JAD-191335_ref5","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.3233\/JAD-191335_ref6","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJMoa0809437","article-title":"Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect","volume":"361","author":"Caselli","year":"2009","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-191335_ref7","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ana.410440226","article-title":"Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer\u2019s disease","volume":"44","author":"Reiman","year":"1998","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-191335_ref8","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.21843","article-title":"APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging","volume":"67","author":"Morris","year":"2010","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-191335_ref9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: Risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-191335_ref10","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0091-3057(96)00431-5","article-title":"Acetylcholine, aging, and Alzheimer\u2019s disease","volume":"56","author":"Muir","year":"1997","journal-title":"Pharmacol Biochem Behav"},{"key":"10.3233\/JAD-191335_ref11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1570159X13666150716165726","article-title":"Alzheimer\u2019s disease: Targeting the cholinergic system","volume":"14","author":"Ferreira-Vieira","year":"2016","journal-title":"Curr Neuropharmacol"},{"key":"10.3233\/JAD-191335_ref12","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.12659\/MSM.892982","article-title":"Butyrylcholinesterase K variant and Alzheimer\u2019s disease risk: A meta-analysis","volume":"21","author":"Wang","year":"2015","journal-title":"Med Sci Monit"},{"key":"10.3233\/JAD-191335_ref13","first-page":"1086","article-title":"DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites","volume":"50","author":"Bartels","year":"1992","journal-title":"Am J Hum Genet"},{"key":"10.3233\/JAD-191335_ref14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0304-3940(02)00014-9","article-title":"Age-dependent association between butyrylcholinesterase K-variant and Alzheimer disease-related neuropathology in human brains","volume":"320","author":"Ghebremedhin","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-191335_ref15","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1046\/j.1529-8817.2004.00110.x","article-title":"Molecular genetics of late-onset Alzheimer\u2019s disease","volume":"68","author":"Kamboh","year":"2004","journal-title":"Ann Hum Genet"},{"key":"10.3233\/JAD-191335_ref16","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.neurobiolaging.2007.11.027","article-title":"Epistasis in sporadic Alzheimer\u2019s disease","volume":"30","author":"Combarros","year":"2009","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-191335_ref17","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.biopsych.2012.08.015","article-title":"Effect of complement CR1 on brain amyloid burden during aging and its modification by APOE genotype","volume":"73","author":"Thambisetty","year":"2013","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-191335_ref18","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.biopsych.2013.01.013","article-title":"CR1 and the \u201cvanishing amyloid\u201d hypothesis of Alzheimer\u2019s disease","volume":"73","author":"Gandy","year":"2013","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-191335_ref19","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neulet.2004.08.057","article-title":"Analysis of association between butyrylcholinesterase K variant and apolipoprotein E genotypes in Alzheimer\u2019s disease","volume":"371","author":"Raygani","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-191335_ref20","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s004390050929","article-title":"Further evidence for a synergistic association between APOE epsilon4 and BCHE-K in confirmed Alzheimer\u2019s disease","volume":"104","author":"Wiebusch","year":"1999","journal-title":"Hum Genet"},{"key":"10.3233\/JAD-191335_ref21","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/hmg\/6.11.1933","article-title":"Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer\u2019s disease","volume":"6","author":"Lehmann","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.3233\/JAD-191335_ref22","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/sj.ejhg.5200351","article-title":"Evaluation of polymorphisms in the presenilin-1 gene and the butyrylcholinesterase gene as risk factors in sporadic Alzheimer\u2019s disease","volume":"7","author":"Tilley","year":"1999","journal-title":"Eur J Hum Genet"},{"key":"10.3233\/JAD-191335_ref23","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.1038\/s41598-019-41578-3","article-title":"Synergy between the alteration in the N-terminal region of butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer\u2019s disease","volume":"9","author":"Jasiecki","year":"2019","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-191335_ref24","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3233\/JAD-150750","article-title":"Association of Butyrylcholinesterase-K allele and Apolipoprotein E epsilon4 allele with cognitive decline in dementia with Lewy bodies and Alzheimer\u2019s disease","volume":"50","author":"Vijayaraghavan","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-191335_ref25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/FPC.0b013e3282f63f29","article-title":"Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer\u2019s disease","volume":"18","author":"Lane","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"10.3233\/JAD-191335_ref26","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3233\/JAD-160373","article-title":"Butyrylcholinesterase K and Apolipoprotein E-epsilon4 reduce the age of onset of Alzheimer\u2019s disease, accelerate cognitive decline, and modulate donepezil response in mild cognitively impaired subjects","volume":"54","author":"De Beaumont","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-191335_ref27","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/mp.2013.19","article-title":"APOE and BCHE as modulators of cerebral amyloid deposition: A florbetapir PET genome-wide association study","volume":"19","author":"Ramanan","year":"2014","journal-title":"Mol Psychiatry"},{"key":"10.3233\/JAD-191335_ref29","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/gerona\/63.12.1416","article-title":"The Baltimore Longitudinal Study of Aging (BLSA): A 50-year-long journey and plans for the future","volume":"63","author":"Ferrucci","year":"2008","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.3233\/JAD-191335_ref30","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/cercor\/10.5.464","article-title":"One-year age changes in MRI brain volumes in older adults","volume":"10","author":"Resnick","year":"2000","journal-title":"Cereb Cortex"},{"key":"10.3233\/JAD-191335_ref31","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neurobiolaging.2018.10.024","article-title":"Predictors of neurodegeneration differ between cognitively normal and subsequently impaired older adults","volume":"75","author":"Armstrong","year":"2019","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-191335_ref32","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0022-2275(20)43176-1","article-title":"Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI","volume":"31","author":"Hixson","year":"1990","journal-title":"J Lipid Res"},{"key":"10.3233\/JAD-191335_ref33","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1515\/cclm.2002.197","article-title":"TaqMan systems for genotyping of disease-related polymorphisms present in the gene encoding apolipoprotein E","volume":"40","author":"Koch","year":"2002","journal-title":"Clin Chem Lab Med"},{"key":"10.3233\/JAD-191335_ref34","doi-asserted-by":"crossref","first-page":"e1000072","DOI":"10.1371\/journal.pgen.1000072","article-title":"A genome-wide association study identifies protein quantitative trait loci (pQTLs)","volume":"4","author":"Melzer","year":"2008","journal-title":"PLoS Genet"},{"key":"10.3233\/JAD-191335_ref35","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/ajmg.b.30932","article-title":"Variants of the serotonin transporter gene and NEO-PI-R Neuroticism: No association in the BLSA and SardiNIA samples","volume":"150B","author":"Terracciano","year":"2009","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.3233\/JAD-191335_ref36","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1212\/WNL.54.11.2072","article-title":"Age-specific incidence rates of Alzheimer\u2019s disease: The Baltimore Longitudinal Study of Aging","volume":"54","author":"Kawas","year":"2000","journal-title":"Neurology"},{"key":"10.3233\/JAD-191335_ref37","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1192\/bjp.114.512.797","article-title":"The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects","volume":"114","author":"Blessed","year":"1968","journal-title":"Br J Psychiatry"},{"issue":"Suppl 1","key":"10.3233\/JAD-191335_ref38","first-page":"177","article-title":"Clinical dementia rating: A reliable and valid diagnostic and staging measure for dementia of the Alzheimer type","volume":"9","author":"Morris","year":"1997","journal-title":"Int Psychogeriatr"},{"key":"10.3233\/JAD-191335_ref39","unstructured":"American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders: DSM-III-R, American Psychiatric Association, Washington, DC."},{"key":"10.3233\/JAD-191335_ref40","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.3233\/JAD-191335_ref41","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"Petersen","year":"2004","journal-title":"J Intern Med"},{"key":"10.3233\/JAD-191335_ref42","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1523\/JNEUROSCI.23-08-03295.2003","article-title":"Longitudinal magnetic resonance imaging studies of older adults: A shrinking brain","volume":"23","author":"Resnick","year":"2003","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-191335_ref43","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.neuroimage.2015.11.073","article-title":"MUSE: MUlti-atlas region Segmentation utilizing Ensembles of registration algorithms and parameters, and locally optimal atlas selection","volume":"127","author":"Doshi","year":"2016","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-191335_ref44","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.neuroimage.2017.10.026","article-title":"Longitudinally and inter-site consistent multi-atlas based parcellation of brain anatomy using harmonized atlases","volume":"166","author":"Erus","year":"2018","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-191335_ref45","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.jalz.2019.07.011","article-title":"Apolipoprotein E epsilon4 allele effects on longitudinal cognitive trajectories are sex and age dependent","volume":"15","author":"Williams","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-191335_ref46","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: A practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"10.3233\/JAD-191335_ref47","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1756-0500-2-105","article-title":"The synergy factor: A statistic to measure interactions in complex diseases","volume":"2","author":"Cortina-Borja","year":"2009","journal-title":"BMC Res Notes"},{"key":"10.3233\/JAD-191335_ref48","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1136\/jnnp.2004.039321","article-title":"Rate of progression of cognitive decline in Alzheimer\u2019s disease: Effect of butyrylcholinesterase K gene variation","volume":"76","author":"Holmes","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-191335_ref49","doi-asserted-by":"crossref","first-page":"17170","DOI":"10.1074\/jbc.M109.004952","article-title":"The butyrylcholinesterase K variant confers structurally derived risks for Alzheimer pathology","volume":"284","author":"Podoly","year":"2009","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-191335_ref50","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/ana.410420613","article-title":"Butyrylcholinesterase in the life cycle of amyloid plaques","volume":"42","author":"Guillozet","year":"1997","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-191335_ref51","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1073\/pnas.0602922103","article-title":"Butyrylcholinesterase attenuates amyloid fibril formation in vitro","volume":"103","author":"Diamant","year":"2006","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-191335","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:08:00Z","timestamp":1777370880000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-191335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,19]]},"references-count":50,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jad-191335","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,19]]}}}